LOST CELLS
VISIONIDALMONDO
Durata: 64 min
Lingua: v.o.sott.it.e eng.
Regia: Valeria Mazzucchi, Antoine Harari
Trama
"Un dono così prezioso da poterlo offrire una sola volta" - questa era la promessa di Cryosave, multinazionale svizzera e leader globale nella conservazione delle cellule staminali, fatta a centinaia di migliaia di neogenitori. Per poche migliaia di franchi, l’azienda offriva di conservare il sangue del cordone ombelicale dei neonati, una sorta di assicurazione contro oltre 80 malattie, una garanzia per il futuro. Ma dietro le brochure si nascondevano strategie di marketing, commissioni occulte e una totale mancanza di controllo. Nel 2019, Cryosave è fallita improvvisamente. Senza avvisare i clienti, ha trasferito in silenzio oltre 300.000 campioni di cellule staminali a un laboratorio in Polonia. Da allora, molti genitori stanno lottando per recuperare ciò che credevano fosse al sicuro.
“A gift so precious, you can only offer it once” was the promise Cryosave, a Swiss multinational and global leader in stem cell banking, made to hundreds of thousands of new parents. For a few thousand francs, the company offered to store their newborn’s umbilical cord blood, an insurance policy against more than 80 illnesses, a safeguard for the future. But behind the brochures lay marketing schemes, hidden commissions, and a lack of oversight. In 2019, Cryosave abruptly went bankrupt. Without notifying its clients, the company quietly transferred over 300,000 stem cell samples to a lab in Poland. Since then, many parents have been fighting to recover what they believed was safely stored.
“A gift so precious, you can only offer it once” was the promise Cryosave, a Swiss multinational and global leader in stem cell banking, made to hundreds of thousands of new parents. For a few thousand francs, the company offered to store their newborn’s umbilical cord blood, an insurance policy against more than 80 illnesses, a safeguard for the future. But behind the brochures lay marketing schemes, hidden commissions, and a lack of oversight. In 2019, Cryosave abruptly went bankrupt. Without notifying its clients, the company quietly transferred over 300,000 stem cell samples to a lab in Poland. Since then, many parents have been fighting to recover what they believed was safely stored.
Info
64 min
Lingua: v.o.sott.it.e eng.
Regia: Valeria Mazzucchi, Antoine Harari
Trama
"Un dono così prezioso da poterlo offrire una sola volta" - questa era la promessa di Cryosave, multinazionale svizzera e leader globale nella conservazione delle cellule staminali, fatta a centinaia di migliaia di neogenitori. Per poche migliaia di franchi, l’azienda offriva di conservare il sangue del cordone ombelicale dei neonati, una sorta di assicurazione contro oltre 80 malattie, una garanzia per il futuro. Ma dietro le brochure si nascondevano strategie di marketing, commissioni occulte e una totale mancanza di controllo. Nel 2019, Cryosave è fallita improvvisamente. Senza avvisare i clienti, ha trasferito in silenzio oltre 300.000 campioni di cellule staminali a un laboratorio in Polonia. Da allora, molti genitori stanno lottando per recuperare ciò che credevano fosse al sicuro.
“A gift so precious, you can only offer it once” was the promise Cryosave, a Swiss multinational and global leader in stem cell banking, made to hundreds of thousands of new parents. For a few thousand francs, the company offered to store their newborn’s umbilical cord blood, an insurance policy against more than 80 illnesses, a safeguard for the future. But behind the brochures lay marketing schemes, hidden commissions, and a lack of oversight. In 2019, Cryosave abruptly went bankrupt. Without notifying its clients, the company quietly transferred over 300,000 stem cell samples to a lab in Poland. Since then, many parents have been fighting to recover what they believed was safely stored.
“A gift so precious, you can only offer it once” was the promise Cryosave, a Swiss multinational and global leader in stem cell banking, made to hundreds of thousands of new parents. For a few thousand francs, the company offered to store their newborn’s umbilical cord blood, an insurance policy against more than 80 illnesses, a safeguard for the future. But behind the brochures lay marketing schemes, hidden commissions, and a lack of oversight. In 2019, Cryosave abruptly went bankrupt. Without notifying its clients, the company quietly transferred over 300,000 stem cell samples to a lab in Poland. Since then, many parents have been fighting to recover what they believed was safely stored.
CONCORSO INTERNAZIONALE
Sono presenti spettacoli su strutture differenti